These malignant cells show a reduced dependency on signals provided by the BM, mainly IL-6, thus prompting us to hypothesize that hyperactive Notch signaling may participate in MM progression by compensating or activating IL-6 proliferative signaling. Here, IL6 is linked to Miyoshi myopathy.